RhumbLine Advisers
POM

RhumbLine Advisers’s Pomdoctor Ltd POM Stock Holding History

RhumbLine Advisers’s Portfolio POM Stock Details POM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192 Hold
42
– – ﹤0.01% 4039
2025
Q4 		$221 Buy
+42
New +$2.74K ﹤0.01% 4082

Other funds holding POM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

RhumbLine Advisers's POM Position: Q1 2026 in Review

RhumbLine Advisers held its Pomdoctor Ltd (POM) position steady in Q1 2026 at 42 shares worth $192. The position accounts for ﹤0.01% of the portfolio, ranked #4039.

RhumbLine Advisers first reported a position in POM in Q4 2025 and has held it in 2 quarters since. The position peaked at $221 in Q4 2025. 10 funds tracked by Wall St. Rank hold POM as of Q1 2026.

  • RhumbLine Advisers held 42 shares of Pomdoctor Ltd worth $192 as of Q1 2026.
  • RhumbLine Advisers left its Pomdoctor Ltd share count unchanged in Q1 2026.
  • Pomdoctor Ltd made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #4039 holding.
  • RhumbLine Advisers first reported a position in Pomdoctor Ltd in Q4 2025 and has held it in 2 quarters since.
  • RhumbLine Advisers's Pomdoctor Ltd position peaked at $221 in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Pomdoctor Ltd as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.